Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesenchymal Stem Cell Extracellular Vesicles for the Treatment of Recessive Dystrophic Epidermolysis Bullosa Wounds

NCT04173650 is registered in ClinicalTrials.gov with Aegle Therapeutics as lead sponsor.

NCT NCT04173650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04173650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesenchymal Stem Cell Extracellular Vesicles for the Treatment of Recessive Dystrophic Epidermolysis Bullosa Wounds
Lead sponsor
Aegle Therapeutics
Phase
Phase 1/2
Overall status
Recruiting
Start date
August 13, 2024
Completion date
March 31, 2026
Enrollment
8 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dystrophic epidermolysis bullosa